{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "16ed596d",
   "metadata": {},
   "outputs": [],
   "source": [
    "import time\n",
    "import requests\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "690572f3",
   "metadata": {},
   "outputs": [],
   "source": [
    "my_df = pd.read_csv('../out', sep = '\\t', dtype=str)\n",
    "dois = my_df['DOI'].dropna().unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fa33a534",
   "metadata": {},
   "outputs": [],
   "source": [
    "#display(my_df)\n",
    "print(len(dois))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ad0773d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "CROSSREF_URL = \"https://api.crossref.org/v1/works/\"\n",
    "def get_crossref(doi):\n",
    "    url = f\"{CROSSREF_URL}{doi}\"\n",
    "    response = requests.get(url, timeout = 5)\n",
    "\n",
    "    if response.status_code == 200:\n",
    "        data = response.json().get(\"message\", {})\n",
    "        r = data.get(\"update-to\", \"Not retracted\")\n",
    "        print(data)\n",
    "        if r != \"Not retracted\":\n",
    "            if r[0]['type'] == 'retraction':\n",
    "                print(\"Retracted\")\n",
    "                print(r)\n",
    "        else:\n",
    "            print('Not retracted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "5216dd85",
   "metadata": {},
   "outputs": [],
   "source": [
    "#get_crossref('10.1128/MCB.00813-07')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "ab679ae4",
   "metadata": {},
   "outputs": [],
   "source": [
    "test = dois[200:400]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "dbf26330",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Checking Retractions:   2%|▌                   | 5/200 [00:52<34:03, 10.48s/DOI]\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyboardInterrupt\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[35]\u001b[39m\u001b[32m, line 37\u001b[39m, in \u001b[36mcheck_dois_in_parallel\u001b[39m\u001b[34m(dois, batch_size, max_workers)\u001b[39m\n\u001b[32m     36\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m tqdm(total=\u001b[38;5;28mlen\u001b[39m(dois), desc=\u001b[33m\"\u001b[39m\u001b[33mChecking Retractions\u001b[39m\u001b[33m\"\u001b[39m, unit=\u001b[33m\"\u001b[39m\u001b[33mDOI\u001b[39m\u001b[33m\"\u001b[39m) \u001b[38;5;28;01mas\u001b[39;00m pbar:\n\u001b[32m---> \u001b[39m\u001b[32m37\u001b[39m \u001b[43m    \u001b[49m\u001b[38;5;28;43;01mfor\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mfuture\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;129;43;01min\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mconcurrent\u001b[49m\u001b[43m.\u001b[49m\u001b[43mfutures\u001b[49m\u001b[43m.\u001b[49m\u001b[43mas_completed\u001b[49m\u001b[43m(\u001b[49m\u001b[43mfuture_to_doi\u001b[49m\u001b[43m)\u001b[49m\u001b[43m:\u001b[49m\n\u001b[32m     38\u001b[39m \u001b[43m        \u001b[49m\u001b[43mdoi\u001b[49m\u001b[43m \u001b[49m\u001b[43m=\u001b[49m\u001b[43m \u001b[49m\u001b[43mfuture_to_doi\u001b[49m\u001b[43m[\u001b[49m\u001b[43mfuture\u001b[49m\u001b[43m]\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/concurrent/futures/_base.py:243\u001b[39m, in \u001b[36mas_completed\u001b[39m\u001b[34m(fs, timeout)\u001b[39m\n\u001b[32m    239\u001b[39m         \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mTimeoutError\u001b[39;00m(\n\u001b[32m    240\u001b[39m                 \u001b[33m'\u001b[39m\u001b[38;5;132;01m%d\u001b[39;00m\u001b[33m (of \u001b[39m\u001b[38;5;132;01m%d\u001b[39;00m\u001b[33m) futures unfinished\u001b[39m\u001b[33m'\u001b[39m % (\n\u001b[32m    241\u001b[39m                 \u001b[38;5;28mlen\u001b[39m(pending), total_futures))\n\u001b[32m--> \u001b[39m\u001b[32m243\u001b[39m \u001b[43mwaiter\u001b[49m\u001b[43m.\u001b[49m\u001b[43mevent\u001b[49m\u001b[43m.\u001b[49m\u001b[43mwait\u001b[49m\u001b[43m(\u001b[49m\u001b[43mwait_timeout\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    245\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m waiter.lock:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/threading.py:622\u001b[39m, in \u001b[36mEvent.wait\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m    621\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m signaled:\n\u001b[32m--> \u001b[39m\u001b[32m622\u001b[39m     signaled = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_cond\u001b[49m\u001b[43m.\u001b[49m\u001b[43mwait\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    623\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m signaled\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/threading.py:320\u001b[39m, in \u001b[36mCondition.wait\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m    319\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m timeout \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m320\u001b[39m     \u001b[43mwaiter\u001b[49m\u001b[43m.\u001b[49m\u001b[43macquire\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    321\u001b[39m     gotit = \u001b[38;5;28;01mTrue\u001b[39;00m\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m: ",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[35]\u001b[39m\u001b[32m, line 47\u001b[39m\n\u001b[32m     43\u001b[39m     \u001b[38;5;66;03m#df[\"Retraction_Status\"] = results  # Add results as a new column\u001b[39;00m\n\u001b[32m     44\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m results\n\u001b[32m---> \u001b[39m\u001b[32m47\u001b[39m status = \u001b[43mcheck_dois_in_parallel\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtest\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     48\u001b[39m \u001b[38;5;66;03m#print(status)\u001b[39;00m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[35]\u001b[39m\u001b[32m, line 33\u001b[39m, in \u001b[36mcheck_dois_in_parallel\u001b[39m\u001b[34m(dois, batch_size, max_workers)\u001b[39m\n\u001b[32m     30\u001b[39m \u001b[38;5;66;03m# dois = df[doi_column].tolist()\u001b[39;00m\n\u001b[32m     31\u001b[39m  results = {}\n\u001b[32m---> \u001b[39m\u001b[32m33\u001b[39m \u001b[43m \u001b[49m\u001b[38;5;28;43;01mwith\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mconcurrent\u001b[49m\u001b[43m.\u001b[49m\u001b[43mfutures\u001b[49m\u001b[43m.\u001b[49m\u001b[43mThreadPoolExecutor\u001b[49m\u001b[43m(\u001b[49m\u001b[43mmax_workers\u001b[49m\u001b[43m=\u001b[49m\u001b[43mmax_workers\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mas\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mexecutor\u001b[49m\u001b[43m:\u001b[49m\n\u001b[32m     34\u001b[39m \u001b[43m     \u001b[49m\u001b[43mfuture_to_doi\u001b[49m\u001b[43m \u001b[49m\u001b[43m=\u001b[49m\u001b[43m \u001b[49m\u001b[43m{\u001b[49m\u001b[43mexecutor\u001b[49m\u001b[43m.\u001b[49m\u001b[43msubmit\u001b[49m\u001b[43m(\u001b[49m\u001b[43mget_crossref_metadata\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdoi\u001b[49m\u001b[43m)\u001b[49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mdoi\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mfor\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mdoi\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;129;43;01min\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mdois\u001b[49m\u001b[43m}\u001b[49m\n\u001b[32m     36\u001b[39m \u001b[43m     \u001b[49m\u001b[38;5;28;43;01mwith\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mtqdm\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtotal\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43mlen\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mdois\u001b[49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdesc\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mChecking Retractions\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43munit\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mDOI\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mas\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mpbar\u001b[49m\u001b[43m:\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/concurrent/futures/_base.py:647\u001b[39m, in \u001b[36mExecutor.__exit__\u001b[39m\u001b[34m(self, exc_type, exc_val, exc_tb)\u001b[39m\n\u001b[32m    646\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__exit__\u001b[39m(\u001b[38;5;28mself\u001b[39m, exc_type, exc_val, exc_tb):\n\u001b[32m--> \u001b[39m\u001b[32m647\u001b[39m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mshutdown\u001b[49m\u001b[43m(\u001b[49m\u001b[43mwait\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\u001b[43m)\u001b[49m\n\u001b[32m    648\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/concurrent/futures/thread.py:235\u001b[39m, in \u001b[36mThreadPoolExecutor.shutdown\u001b[39m\u001b[34m(self, wait, cancel_futures)\u001b[39m\n\u001b[32m    233\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m wait:\n\u001b[32m    234\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m t \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m._threads:\n\u001b[32m--> \u001b[39m\u001b[32m235\u001b[39m         \u001b[43mt\u001b[49m\u001b[43m.\u001b[49m\u001b[43mjoin\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/threading.py:1112\u001b[39m, in \u001b[36mThread.join\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m   1109\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\u001b[33m\"\u001b[39m\u001b[33mcannot join current thread\u001b[39m\u001b[33m\"\u001b[39m)\n\u001b[32m   1111\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m timeout \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1112\u001b[39m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_wait_for_tstate_lock\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m   1113\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m   1114\u001b[39m     \u001b[38;5;66;03m# the behavior of a negative timeout isn't documented, but\u001b[39;00m\n\u001b[32m   1115\u001b[39m     \u001b[38;5;66;03m# historically .join(timeout=x) for x<0 has acted as if timeout=0\u001b[39;00m\n\u001b[32m   1116\u001b[39m     \u001b[38;5;28mself\u001b[39m._wait_for_tstate_lock(timeout=\u001b[38;5;28mmax\u001b[39m(timeout, \u001b[32m0\u001b[39m))\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/usr/lib/python3.11/threading.py:1132\u001b[39m, in \u001b[36mThread._wait_for_tstate_lock\u001b[39m\u001b[34m(self, block, timeout)\u001b[39m\n\u001b[32m   1129\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m\n\u001b[32m   1131\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1132\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[43mlock\u001b[49m\u001b[43m.\u001b[49m\u001b[43macquire\u001b[49m\u001b[43m(\u001b[49m\u001b[43mblock\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m:\n\u001b[32m   1133\u001b[39m         lock.release()\n\u001b[32m   1134\u001b[39m         \u001b[38;5;28mself\u001b[39m._stop()\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m: "
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import concurrent.futures\n",
    "import pandas as pd\n",
    "from tqdm import tqdm  \n",
    "\n",
    "CROSSREF_URL = \"https://api.crossref.org/v1/works/\"\n",
    "\n",
    "def get_crossref_metadata(doi):\n",
    "    \"\"\"Fetch metadata for a given DOI and check if it's retracted.\"\"\"\n",
    "    url = f\"{CROSSREF_URL}{doi}\"\n",
    "    try:\n",
    "        response = requests.get(url, timeout = 25)\n",
    "        if response.status_code == 200:\n",
    "            data = response.json().get(\"message\", {})\n",
    "            r = data.get(\"update-to\", \"Not retracted\")\n",
    "            if r != \"Not retracted\":\n",
    "                if r[0].get('type') == 'retraction':\n",
    "                    return \"Retracted\"\n",
    "                else:\n",
    "                    return r[0].get('type')\n",
    "            else:\n",
    "                return \"Not retracted\"\n",
    "        else:\n",
    "            return f\"Error: {response.status_code}\"\n",
    "    except requests.exceptions.RequestException as e:\n",
    "        return f\"Request Error: {e}\"\n",
    "\n",
    "def check_dois_in_parallel(dois, batch_size=10, max_workers=1):\n",
    "    \"\"\"Processes DOIs in parallel and saves results in a new DataFrame column.\"\"\"\n",
    "   # dois = df[doi_column].tolist()\n",
    "    results = {}\n",
    "\n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor:\n",
    "        future_to_doi = {executor.submit(get_crossref_metadata, doi): doi for doi in dois}\n",
    "        \n",
    "        with tqdm(total=len(dois), desc=\"Checking Retractions\", unit=\"DOI\") as pbar:\n",
    "            for future in concurrent.futures.as_completed(future_to_doi):\n",
    "                doi = future_to_doi[future]\n",
    "                status = future.result()\n",
    "                results[doi] = status\n",
    "                pbar.update(1)  # Update progress bar after each DOI\n",
    "\n",
    "    #df[\"Retraction_Status\"] = results  # Add results as a new column\n",
    "    return results\n",
    "\n",
    "\n",
    "status = check_dois_in_parallel(test)\n",
    "#print(status)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "2fd86974",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['Record ID', 'Title', 'Subject', 'Institution', 'Journal', 'Publisher',\n",
      "       'Country', 'Author', 'URLS', 'ArticleType', 'RetractionDate',\n",
      "       'RetractionDOI', 'RetractionPubMedID', 'OriginalPaperDate',\n",
      "       'OriginalPaperDOI', 'OriginalPaperPubMedID', 'RetractionNature',\n",
      "       'Reason', 'Paywalled', 'Notes'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df = pd.read_csv('retraction_watch.csv',  dtype=str)\n",
    "print(df.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "a5c03639",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+Duplication of/in Image;+Investigation by Thir...\n"
     ]
    }
   ],
   "source": [
    "print(df['Reason'][df['OriginalPaperDOI'] == '10.1016/j.biopha.2018.03.122'].to_string(index = False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "93bda29c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+Author Unresponsive;+Concerns/Issues about Referencing/Attributions;+Concerns/Issues with Peer Review;+Fake Peer Review;+Investigation by Journal/Publisher;+Unreliable Results and/or Conclusions;\n",
      "10.1016/j.biopha.2018.03.122\n",
      "      Record ID  \\\n",
      "18621     44005   \n",
      "\n",
      "                                                                                     Title  \\\n",
      "18621  MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1   \n",
      "\n",
      "                                                               Subject  \\\n",
      "18621  (BLS) Biology - Cancer;(BLS) Biology - Cellular;(BLS) Genetics;   \n",
      "\n",
      "                                                                                                                                                                                                                                                 Institution  \\\n",
      "18621  Department of Thyroid Surgery, The First Hospital of Jilin University, 71# Xinmin Street, Changchun 130021, China; Departments of Hepatobiliary Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun 130033, China;   \n",
      "\n",
      "                             Journal Publisher Country  \\\n",
      "18621  Biomedicine & Pharmacotherapy  Elsevier   China   \n",
      "\n",
      "                                                       Author URLS  \\\n",
      "18621  Rui Li;Bingfei Dong;Zhangmin Wang;Tao Jiang;Guang Chen  NaN   \n",
      "\n",
      "             ArticleType  RetractionDate                 RetractionDOI  \\\n",
      "18621  Research Article;  4/21/2023 0:00  10.1016/j.biopha.2023.114723   \n",
      "\n",
      "      RetractionPubMedID OriginalPaperDate              OriginalPaperDOI  \\\n",
      "18621           37088668     4/5/2018 0:00  10.1016/j.biopha.2018.03.122   \n",
      "\n",
      "      OriginalPaperPubMedID RetractionNature  \\\n",
      "18621              29710554       Retraction   \n",
      "\n",
      "                                                                                              Reason  \\\n",
      "18621  +Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;   \n",
      "\n",
      "      Paywalled  \\\n",
      "18621        No   \n",
      "\n",
      "                                                                           Notes  \n",
      "18621  see also: https://pubpeer.com/publications/0DA940799BE0D567BAC4659CDAB13F  \n",
      "['+Duplication of/in Image', '+Investigation by Third Party', '+Paper Mill', '+Results Not Reproducible', '']\n"
     ]
    }
   ],
   "source": [
    "print(df['Reason'][10])\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "my_df = pd.read_csv('Retracted_sample', sep = '\\t', dtype=str)\n",
    "status = my_df['Retracted DOI']\n",
    "for i in status:\n",
    "    a = df['OriginalPaperDOI'].isin([i])\n",
    "    if not df[a].empty:\n",
    "        print(i)\n",
    "        print(df[a])\n",
    "        print(df[a]['Reason'].to_string(index = False).split(';'))\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "80273a0f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "73\n",
      "{'10.1016/j.biopha.2018.03.122': '+Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;', '10.1016/j.lfs.2020.117519': '+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;', '10.1016/j.omtn.2019.12.014': '+Concerns/Issues About Image;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Image;', '10.1016/j.omtn.2019.12.025': '+Concerns/Issues About Data;+Concerns/Issues about Results and/or Conclusions;', '10.1016/j.biopha.2018.05.078': '+Author Unresponsive;+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Upgrade/Update of Prior Notice(s);\\n                                                                                                  +Concerns/Issues About Data;+Concerns/Issues About Image;+Investigation by Journal/Publisher;+Updated to Retraction;', '10.1016/j.yexmp.2020.104380': '+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;', '10.1007/s10617-018-9205-4': '+Concerns/Issues about Referencing/Attributions;+Fake Peer Review;+Rogue Editor;', '10.1186/s12935-016-0349-7': '+Duplication of/in Image;+Investigation by Company/Institution;+Unreliable Results and/or Conclusions;', '10.1016/j.intimp.2017.06.021': '+Concerns/Issues About Data;+Concerns/Issues About Image;+Concerns/Issues about Third Party Involvement;', '10.3727/096504017X14954923820137': '+Investigation by Third Party;+Notice - Limited or No Information;+Paper Mill;+Removed;', '10.3945/jn.115.218883': '+Concerns/Issues About Data;+Investigation by Journal/Publisher;+Upgrade/Update of Prior Notice(s);\\n  +Concerns/Issues About Data;+Lack of IRB/IACUC Approval and/or Compliance;+Updated to Retraction;', '10.1016/j.ijleo.2017.11.036': '+Duplication of/in Image;+Unreliable Results and/or Conclusions;', '10.1016/j.amc.2021.126868': '+Concerns/Issues About Authorship/Affiliation;+Date of Article and/or Notice Unknown;+Unreliable Results and/or Conclusions;', '10.1016/j.amc.2021.126883': '+Concerns/Issues About Authorship/Affiliation;+Concerns/Issues About Data;+Date of Article and/or Notice Unknown;+Unreliable Results and/or Conclusions;', '10.1016/j.biopha.2018.04.193': '+Duplication of Data;+Duplication of/in Image;+Euphemisms for Duplication;+Investigation by Third Party;', '10.1186/1471-2407-14-218': '+Concerns/Issues About Data;+Concerns/Issues About Image;+Unreliable Data;', '10.1016/j.canlet.2020.02.014': '+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;', '10.1016/j.avb.2021.101706': '+Concerns/Issues with Peer Review;+Doing the Right Thing;+Error by Journal/Publisher;+Rogue Editor;+Removed;', '10.1007/s13198-021-01263-z': '+Concerns/Issues about Referencing/Attributions;+Fake Peer Review;+Rogue Editor;+Unreliable Results and/or Conclusions;', '10.1016/j.bbrc.2017.01.170': '+Results Not Reproducible;', '10.1016/j.biopha.2017.09.074': '+Concerns/Issues About Data;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Data;+Plagiarism of Image;+Unreliable Data;', '10.1074/jbc.M112.442939': '+Concerns/Issues About Image;+Duplication of/in Image;+Manipulation of Images;', '10.1038/emm.2017.98': '+Concerns/Issues About Image;+Duplication of/in Image;', '10.1016/j.biopha.2015.12.018': '+Concerns/Issues About Image;+Falsification/Fabrication of Image;+Investigation by Company/Institution;+Investigation by Journal/Publisher;+Misconduct - Official Investigation(s) and/or Finding(s);+Misconduct by Author;+Objections by Third Party;+Original Data and/or Images not Provided and/or not Available;', '10.1016/j.omtn.2020.09.020': '+Falsification/Fabrication of Data;+Investigation by Journal/Publisher;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Unreliable Results and/or Conclusions;', '10.1016/j.ajp.2020.102052': '+Duplication of/in Article;+False/Forged Affiliation;+False/Forged Authorship;+Upgrade/Update of Prior Notice(s);\\n                                                               +Duplication of/in Article;+Updated to Retraction;'}\n",
      "26\n"
     ]
    }
   ],
   "source": [
    "print(len(status))\n",
    "#print(status.keys())\n",
    "\"\"\"reason = {}\n",
    "for key , value in status.items():\n",
    "    if value == 'Retracted':\n",
    "        reason[key] = value\n",
    "res = sum(x == 'Retracted' for x in status.values())\n",
    "print(res)\n",
    "print(len(reason))\n",
    "\"\"\"\n",
    "retracted = {}\n",
    "for i in status:\n",
    "    a = df['OriginalPaperDOI'].isin([i])\n",
    "    if not df[a].empty:\n",
    "        retracted[i] = df[a]['Reason'].to_string(index = False)\n",
    "        \n",
    "\"\"\"for doi in reason.keys():\n",
    "    a = df['OriginalPaperDOI'].isin([doi])\n",
    "    if not df[a].empty:\n",
    "        #reason.append(df[a]['Reason'].to_string(index = False))\n",
    "        #retracted[doi].append(df[a]['Reason'].to_string(index = False))\n",
    "        retracted[doi] = df[a]['Reason'].to_string(index = False)\n",
    "            #break\"\"\"\n",
    "print(retracted)\n",
    "print(len(retracted))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "76b50b3b",
   "metadata": {},
   "outputs": [],
   "source": [
    "a = df[\"OriginalPaperDOI\"].isin(['10.1016/j.lfs.2020.117519'])\n",
    "print(df[a].empty)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f1cfb9c2",
   "metadata": {},
   "outputs": [],
   "source": [
    "reason = []\n",
    "for doi in retracted.keys():\n",
    "    a = df['OriginalPaperDOI'].isin([doi])\n",
    "    if not df[a].empty:\n",
    "        print(doi)\n",
    "        print(df[a]['Reason'].to_string(index = False))#.split(';'))\n",
    "        reason.append(df[a]['Reason'].to_string(index = False))\n",
    "            #break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "85cb8ae5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "26\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DOI</th>\n",
       "      <th>Reasons</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10.1016/j.biopha.2018.03.122</td>\n",
       "      <td>+Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10.1016/j.lfs.2020.117519</td>\n",
       "      <td>+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            DOI  \\\n",
       "0  10.1016/j.biopha.2018.03.122   \n",
       "1     10.1016/j.lfs.2020.117519   \n",
       "\n",
       "                                                                                                                                                          Reasons  \n",
       "0                                                                   +Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;  \n",
       "1  +Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Citing DOI</th>\n",
       "      <th>Citation ID</th>\n",
       "      <th>CC paragraph</th>\n",
       "      <th>CC prev_next</th>\n",
       "      <th>Retracted DOI</th>\n",
       "      <th>Reasons</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10.3390/cancers12113118</td>\n",
       "      <td>B46-cancers-12-03118</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>10.1016/j.biopha.2018.03.122</td>\n",
       "      <td>+Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10.3390/cancers12113118</td>\n",
       "      <td>B64-cancers-12-03118</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>10.1016/j.lfs.2020.117519</td>\n",
       "      <td>+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10.3390/cancers12113118</td>\n",
       "      <td>B97-cancers-12-03118</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>10.1016/j.omtn.2019.12.014</td>\n",
       "      <td>+Concerns/Issues About Image;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Image;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10.3390/cancers12113118</td>\n",
       "      <td>B115-cancers-12-03118</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>10.1016/j.omtn.2019.12.025</td>\n",
       "      <td>+Concerns/Issues About Data;+Concerns/Issues about Results and/or Conclusions;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10.3390/cancers12113118</td>\n",
       "      <td>B139-cancers-12-03118</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].</td>\n",
       "      <td>10.1016/j.biopha.2018.05.078</td>\n",
       "      <td>+Author Unresponsive;+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Upgrade/Update of Prior Notice(s);\\n                                                                                                  +Concerns/Issues About Data;+Concerns/Issues About Image;+Investigation by Journal/Publisher;+Updated to Retraction;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>10.1186/s13046-015-0145-6</td>\n",
       "      <td>CR22</td>\n",
       "      <td>To determine the correlation of dysregulated miRNAs with DDP resistance, frequently reported miRNAs related to GC were chosen to distinguish the difference between resistance and sensitivity of GC cells [ 13 - 22 ]. We detected the IC 50  of sensitive and resistance cells first and found that the IC 50  of 7901/DDP (Figure  1 A) or BGC-823/DDP (Figure  1 B) was significantly higher than that in respective sensitive cells. Then, we found that a panel of miRNAs was dysregulated in 7901/DDP cells compared with 7901 cells. Among the 10 miRNAs, miR-223 was found to be most significantly changed in 7901/DDP cells (P &lt; 0.01) (Figure  1 C). The result was similar in another GC cell line (P &lt; 0.01; Figure  1 D). We co-cultured 7901 and BGC-823 cells with different MOIs of H. pylori and found that miR-223 expression increased with MOIs of H. pylori infection (Additional file  2 : Figure S1A). We also detected miR-223 expression in tumor and control tissues and found that miR-223 expression was significantly higher in tumors (Figure  1 E, p &lt; 0.05) and it expressed especially higher in stage III/IV patients (Figure  1 F, p &lt; 0.05). We further divided the patients into H. pylori infected and non-infected groups and found that miR-223 was significantly higher in H. pylori infected tumor and control adjacent tissues (Additional file  2 : Figure S1B). Taken together, these data suggested that up-regulation of miR-223 might have important roles in the development of GC and DDP resistance in GC cells, especially under H. pylori infection state. Figure 1 \\n miR-223 expression in cells and tissues. (A)  The IC 50  level of 7901 and 7901/DDP;  (B)  The IC50 level of BGC-823 and BGC-823/DDP;  (C)  qRT-PCR detection of differential miRNAs expression in 7901 and 7901/DDP cells;  (D)  qRT-PCR detection of differential miRNAs expression in BGC-823 and BGC-823/DDP cells;  (E)  qRT-PCR detection of miR-223 in tumor and control tissues;  (F)  qRT-PCR detection of miR-223 in different stages of tumor tissues. (*p &lt; 0.05, **p &lt; 0.01).</td>\n",
       "      <td>To determine the correlation of dysregulated miRNAs with DDP resistance, frequently reported miRNAs related to GC were chosen to distinguish the difference between resistance and sensitivity of GC cells [ 13 - 22 ]. We detected the IC 50  of sensitive and resistance cells first and found that the IC 50  of 7901/DDP (Figure  1 A) or BGC-823/DDP (Figure  1 B) was significantly higher than that in respective sensitive cells.</td>\n",
       "      <td>10.1186/1471-2407-14-218</td>\n",
       "      <td>+Concerns/Issues About Data;+Concerns/Issues About Image;+Unreliable Data;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>10.1186/s13046-021-01964-0</td>\n",
       "      <td>CR27</td>\n",
       "      <td>Since their first discoveries, many circRNAs have been implicated in diseases particularly in cancers [ 15 ,  16 ]. Some function as oncogenes while some act as tumor suppressors. Some circRNAs have complicated roles depending on types of cancers [ 17 ]. In thyroid cancers, aberrant expressions of circRNAs have been reported as well [ 27 ]. For example, circBACH2 contributes to papillary thyroid carcinoma [ 28 ]. Emerging evidence indicates that circPVT1 is an oncogenic circRNA. It promotes the development and metastasis of colorectal cancer [ 29 ]. Also, it accelerates proliferation, migration, and invasion of non-small-cell lung cancer cells [ 19 ,  30 ,  31 ]. However, in MTC, the role of circPVT1 is not clear. Here, we showed that circPVT1 contributed to MTC development. Knockdown of circPVT1 suppressed MTC cell proliferation, migration and invasion, and inhibited MTC tumor growth and lung metastasis  in vivo . Our study, together with previous studies [ 18 ,  19 ,  29 – 31 ], supports the model that circPVT1 is a general oncogene non-coding RNA. Due to the circular structure, circRNAs are usually very stable and thus can be used as diagnosis markers of diseases. Here, we showed that high level of circPVT1 correlated well with the poor prognosis of MTC. Therefore, elevation of circPVT1 could potentially serve as an early diagnosis marker for MTC.</td>\n",
       "      <td>Some circRNAs have complicated roles depending on types of cancers [ 17 ]. In thyroid cancers, aberrant expressions of circRNAs have been reported as well [ 27 ]. For example, circBACH2 contributes to papillary thyroid carcinoma [ 28 ].</td>\n",
       "      <td>10.1016/j.omtn.2019.12.014</td>\n",
       "      <td>+Concerns/Issues About Image;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Image;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>10.18632/aging.103642</td>\n",
       "      <td>r33</td>\n",
       "      <td>We also demonstrate that MiR-421 inhibits ROCK1 expression by directly binding to the 3′-UTR of ROCK1 in PTC cells. ROCK1 functions as an oncogene in many cancer types, such as non-small lung cancer, breast cancer, ovarian cancer and prostate cancer [ 31 ,  32 ]. ROCK1 is overexpressed in PTC tissues and promotes PTC cell proliferation and invasion [ 33 ,  34 ]. Previous reports also show that miR-26a [ 35 ], miR-584 [ 36 ] and miR-150 [ 37 ] directly target ROCK1 in PTC. We demonstrate that knockdown of DLEU1 decreases ROCK1 expression in TPC-1 cells, but, this effect is reversed by co-transfection with the miR-421 inhibitor. Moreover, ROCK1 expression negatively correlates with miR-421 levels and positive correlates with DLEU1 levels in PTC tissues. ROCK1 overexpression partially rescues the reduced proliferation, migration and invasion of DLEU1-knockdown TPC-1 cells. These results demonstrate that DLEUI exerts its oncogenic role in PTC by regulating the miR-421/ROCK1 axis.</td>\n",
       "      <td>ROCK1 functions as an oncogene in many cancer types, such as non-small lung cancer, breast cancer, ovarian cancer and prostate cancer [ 31 ,  32 ]. ROCK1 is overexpressed in PTC tissues and promotes PTC cell proliferation and invasion [ 33 ,  34 ]. Previous reports also show that miR-26a [ 35 ], miR-584 [ 36 ] and miR-150 [ 37 ] directly target ROCK1 in PTC.</td>\n",
       "      <td>10.1016/j.biopha.2018.03.122</td>\n",
       "      <td>+Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>10.1186/s12967-021-02971-7</td>\n",
       "      <td>CR11</td>\n",
       "      <td>Nanomaterials (NPs) have been increasingly used in biomedical fields, especially in healthcare, which can be coupled with various antibody and luminescent labeling [ 6 ]. Due to their small size (100 nm) and surface paintability, NPs can also serve as effective tracers in cancer diagnosis with therapy [ 7 ]. In particular, 18 nm Fe 3 O 4  magnetic nanoparticles (MNPs) are known to exhibit better magnetic particle and magnetic resonance imaging properties, which is designed for precision imaging and cancer therapy [ 8 ]. More interestingly, a recent study highlighted that MNPs can serve as a participant in a better efficacy against lung adenocarcinoma as a drug target [ 9 ]. Meanwhile, MNPs further serve as contributors to nanotriggers, which possess the ability to control cell function [ 10 ]. On the other hand, Baculoviral IAP repeat containing 5 (BIRC5) is up-regulated in lung adenocarcinoma cells and tissues, wherein radiosensitivity was found to influence the dependance on BIRC5 expression [ 11 ]. Moreover, genes can be inhibited by antisense oligodeoxynucleotide (AS-ODN) or by small interference RNA (siRNA), and previously been highlighted as a promising treatment avenue for lung adenocarcinoma [ 12 ]. Besides, death receptor 5 (DR5) is known to trigger cell death in various tumor cells [ 13 ], and further regarded as a prognostic biomarker for non-small cell lung adenocarcinoma [ 14 ]. However, the relationship among BIRC5, AS-ODN, and DR5 remains elusive and warrants further investigation. In the current study, we presumed that Fe 3 O 4  MNPs may deliver BIRC5 and AS-ODN to tumor cells, which may be applied in radiotherapy, and set out to perform a series of experiments to investigate the molecular mechanism underlying small interfering RNA against BIRC5 (siBIRC5) in lung adenocarcinoma, hoping to discover some promising strategy to increase the radiosensitivity.</td>\n",
       "      <td>Meanwhile, MNPs further serve as contributors to nanotriggers, which possess the ability to control cell function [ 10 ]. On the other hand, Baculoviral IAP repeat containing 5 (BIRC5) is up-regulated in lung adenocarcinoma cells and tissues, wherein radiosensitivity was found to influence the dependance on BIRC5 expression [ 11 ]. Moreover, genes can be inhibited by antisense oligodeoxynucleotide (AS-ODN) or by small interference RNA (siRNA), and previously been highlighted as a promising treatment avenue for lung adenocarcinoma [ 12 ].</td>\n",
       "      <td>10.1016/j.omtn.2020.09.020</td>\n",
       "      <td>+Falsification/Fabrication of Data;+Investigation by Journal/Publisher;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Unreliable Results and/or Conclusions;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>10.1186/s12967-021-02971-7</td>\n",
       "      <td>CR11</td>\n",
       "      <td>Subsequent experimentation in our study revealed that NPs exerted a suppressive effect on BIRC5 expression in lung adenocarcinoma cells. As a member of the inhibitor of apoptosis protein family, BIRC5 is known to be up-regulated in various malignancies [ 20 ]. BIRC5 is also reported to be one of the prognostic markers for lung adenocarcinoma [ 21 ]. Moreover, BIRC5 up-regulation was previously documented in lung adenocarcinoma cells and tissues, wherein = radiosensitivity could affect the dependence on BIRC5 expression [ 11 ]. Consistently, RT-qPCR and Western blotting results in our study revealed that BIRC5 was highly-expressed in lung adenocarcinoma. Although the regulating relation between NPs and BIRC5 remains elusive, Survivin, another member of inhibitor of apoptosis protein family, is known to be knocked-down by NPs in MG-63 cells [ 22 ,  23 ]. Expanding on this, our findings displayed that Fe 3 O 4  MNPs could reduce the BIRC5 expression in lung adenocarcinoma cells by delivering siBIRC5 and AS-ODN into lung adenocarcinoma cells simultaneously. On the other hand, the expression of DR5, a member of the tumor necrosis factor receptor superfamily (TNFRSF10B), was previously correlated with radiosensitivity in tumor cells [ 24 ]. Interestingly, the current study demonstrated that NPs could increase the DR5 expression by silencing BIRC5. NPs are further known to possess the ability to up-regulate DR5 to promote the apoptosis of colorectal cancer cells [ 25 ]. To our best knowledge, studies investigating the correlation between BIRC5 and DR5 remain scarce, therefore it would be plausible to suggest that BIRC5/DR5 may be a novel strategy involved in lung adenocarcinoma therapy. Furthermore, we also uncovered that co-treatment of NPs and radiotherapy brought about marked elevation in cell apoptosis of lung adenocarcinoma, as evidenced by up-regulated Caspase-3 expressions. Consistently, a prior study illustrated that RBCm-OM/PLGA nanoparticles promoted the apoptosis of non-small-cell lung adenocarcinoma cells by reducing the Bcl-2 expression and elevating Caspase-3 levels [ 26 ].</td>\n",
       "      <td>BIRC5 is also reported to be one of the prognostic markers for lung adenocarcinoma [ 21 ]. Moreover, BIRC5 up-regulation was previously documented in lung adenocarcinoma cells and tissues, wherein = radiosensitivity could affect the dependence on BIRC5 expression [ 11 ]. Consistently, RT-qPCR and Western blotting results in our study revealed that BIRC5 was highly-expressed in lung adenocarcinoma.</td>\n",
       "      <td>10.1016/j.omtn.2020.09.020</td>\n",
       "      <td>+Falsification/Fabrication of Data;+Investigation by Journal/Publisher;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Unreliable Results and/or Conclusions;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>73 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Citing DOI            Citation ID  \\\n",
       "0      10.3390/cancers12113118   B46-cancers-12-03118   \n",
       "1      10.3390/cancers12113118   B64-cancers-12-03118   \n",
       "2      10.3390/cancers12113118   B97-cancers-12-03118   \n",
       "3      10.3390/cancers12113118  B115-cancers-12-03118   \n",
       "4      10.3390/cancers12113118  B139-cancers-12-03118   \n",
       "..                         ...                    ...   \n",
       "68   10.1186/s13046-015-0145-6                   CR22   \n",
       "69  10.1186/s13046-021-01964-0                   CR27   \n",
       "70       10.18632/aging.103642                    r33   \n",
       "71  10.1186/s12967-021-02971-7                   CR11   \n",
       "72  10.1186/s12967-021-02971-7                   CR11   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             CC paragraph  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "..                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ...   \n",
       "68                                                                               To determine the correlation of dysregulated miRNAs with DDP resistance, frequently reported miRNAs related to GC were chosen to distinguish the difference between resistance and sensitivity of GC cells [ 13 - 22 ]. We detected the IC 50  of sensitive and resistance cells first and found that the IC 50  of 7901/DDP (Figure  1 A) or BGC-823/DDP (Figure  1 B) was significantly higher than that in respective sensitive cells. Then, we found that a panel of miRNAs was dysregulated in 7901/DDP cells compared with 7901 cells. Among the 10 miRNAs, miR-223 was found to be most significantly changed in 7901/DDP cells (P < 0.01) (Figure  1 C). The result was similar in another GC cell line (P < 0.01; Figure  1 D). We co-cultured 7901 and BGC-823 cells with different MOIs of H. pylori and found that miR-223 expression increased with MOIs of H. pylori infection (Additional file  2 : Figure S1A). We also detected miR-223 expression in tumor and control tissues and found that miR-223 expression was significantly higher in tumors (Figure  1 E, p < 0.05) and it expressed especially higher in stage III/IV patients (Figure  1 F, p < 0.05). We further divided the patients into H. pylori infected and non-infected groups and found that miR-223 was significantly higher in H. pylori infected tumor and control adjacent tissues (Additional file  2 : Figure S1B). Taken together, these data suggested that up-regulation of miR-223 might have important roles in the development of GC and DDP resistance in GC cells, especially under H. pylori infection state. Figure 1 \\n miR-223 expression in cells and tissues. (A)  The IC 50  level of 7901 and 7901/DDP;  (B)  The IC50 level of BGC-823 and BGC-823/DDP;  (C)  qRT-PCR detection of differential miRNAs expression in 7901 and 7901/DDP cells;  (D)  qRT-PCR detection of differential miRNAs expression in BGC-823 and BGC-823/DDP cells;  (E)  qRT-PCR detection of miR-223 in tumor and control tissues;  (F)  qRT-PCR detection of miR-223 in different stages of tumor tissues. (*p < 0.05, **p < 0.01).   \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Since their first discoveries, many circRNAs have been implicated in diseases particularly in cancers [ 15 ,  16 ]. Some function as oncogenes while some act as tumor suppressors. Some circRNAs have complicated roles depending on types of cancers [ 17 ]. In thyroid cancers, aberrant expressions of circRNAs have been reported as well [ 27 ]. For example, circBACH2 contributes to papillary thyroid carcinoma [ 28 ]. Emerging evidence indicates that circPVT1 is an oncogenic circRNA. It promotes the development and metastasis of colorectal cancer [ 29 ]. Also, it accelerates proliferation, migration, and invasion of non-small-cell lung cancer cells [ 19 ,  30 ,  31 ]. However, in MTC, the role of circPVT1 is not clear. Here, we showed that circPVT1 contributed to MTC development. Knockdown of circPVT1 suppressed MTC cell proliferation, migration and invasion, and inhibited MTC tumor growth and lung metastasis  in vivo . Our study, together with previous studies [ 18 ,  19 ,  29 – 31 ], supports the model that circPVT1 is a general oncogene non-coding RNA. Due to the circular structure, circRNAs are usually very stable and thus can be used as diagnosis markers of diseases. Here, we showed that high level of circPVT1 correlated well with the poor prognosis of MTC. Therefore, elevation of circPVT1 could potentially serve as an early diagnosis marker for MTC.   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         We also demonstrate that MiR-421 inhibits ROCK1 expression by directly binding to the 3′-UTR of ROCK1 in PTC cells. ROCK1 functions as an oncogene in many cancer types, such as non-small lung cancer, breast cancer, ovarian cancer and prostate cancer [ 31 ,  32 ]. ROCK1 is overexpressed in PTC tissues and promotes PTC cell proliferation and invasion [ 33 ,  34 ]. Previous reports also show that miR-26a [ 35 ], miR-584 [ 36 ] and miR-150 [ 37 ] directly target ROCK1 in PTC. We demonstrate that knockdown of DLEU1 decreases ROCK1 expression in TPC-1 cells, but, this effect is reversed by co-transfection with the miR-421 inhibitor. Moreover, ROCK1 expression negatively correlates with miR-421 levels and positive correlates with DLEU1 levels in PTC tissues. ROCK1 overexpression partially rescues the reduced proliferation, migration and invasion of DLEU1-knockdown TPC-1 cells. These results demonstrate that DLEUI exerts its oncogenic role in PTC by regulating the miR-421/ROCK1 axis.   \n",
       "71                                                                                                                                                                                                                         Nanomaterials (NPs) have been increasingly used in biomedical fields, especially in healthcare, which can be coupled with various antibody and luminescent labeling [ 6 ]. Due to their small size (100 nm) and surface paintability, NPs can also serve as effective tracers in cancer diagnosis with therapy [ 7 ]. In particular, 18 nm Fe 3 O 4  magnetic nanoparticles (MNPs) are known to exhibit better magnetic particle and magnetic resonance imaging properties, which is designed for precision imaging and cancer therapy [ 8 ]. More interestingly, a recent study highlighted that MNPs can serve as a participant in a better efficacy against lung adenocarcinoma as a drug target [ 9 ]. Meanwhile, MNPs further serve as contributors to nanotriggers, which possess the ability to control cell function [ 10 ]. On the other hand, Baculoviral IAP repeat containing 5 (BIRC5) is up-regulated in lung adenocarcinoma cells and tissues, wherein radiosensitivity was found to influence the dependance on BIRC5 expression [ 11 ]. Moreover, genes can be inhibited by antisense oligodeoxynucleotide (AS-ODN) or by small interference RNA (siRNA), and previously been highlighted as a promising treatment avenue for lung adenocarcinoma [ 12 ]. Besides, death receptor 5 (DR5) is known to trigger cell death in various tumor cells [ 13 ], and further regarded as a prognostic biomarker for non-small cell lung adenocarcinoma [ 14 ]. However, the relationship among BIRC5, AS-ODN, and DR5 remains elusive and warrants further investigation. In the current study, we presumed that Fe 3 O 4  MNPs may deliver BIRC5 and AS-ODN to tumor cells, which may be applied in radiotherapy, and set out to perform a series of experiments to investigate the molecular mechanism underlying small interfering RNA against BIRC5 (siBIRC5) in lung adenocarcinoma, hoping to discover some promising strategy to increase the radiosensitivity.   \n",
       "72  Subsequent experimentation in our study revealed that NPs exerted a suppressive effect on BIRC5 expression in lung adenocarcinoma cells. As a member of the inhibitor of apoptosis protein family, BIRC5 is known to be up-regulated in various malignancies [ 20 ]. BIRC5 is also reported to be one of the prognostic markers for lung adenocarcinoma [ 21 ]. Moreover, BIRC5 up-regulation was previously documented in lung adenocarcinoma cells and tissues, wherein = radiosensitivity could affect the dependence on BIRC5 expression [ 11 ]. Consistently, RT-qPCR and Western blotting results in our study revealed that BIRC5 was highly-expressed in lung adenocarcinoma. Although the regulating relation between NPs and BIRC5 remains elusive, Survivin, another member of inhibitor of apoptosis protein family, is known to be knocked-down by NPs in MG-63 cells [ 22 ,  23 ]. Expanding on this, our findings displayed that Fe 3 O 4  MNPs could reduce the BIRC5 expression in lung adenocarcinoma cells by delivering siBIRC5 and AS-ODN into lung adenocarcinoma cells simultaneously. On the other hand, the expression of DR5, a member of the tumor necrosis factor receptor superfamily (TNFRSF10B), was previously correlated with radiosensitivity in tumor cells [ 24 ]. Interestingly, the current study demonstrated that NPs could increase the DR5 expression by silencing BIRC5. NPs are further known to possess the ability to up-regulate DR5 to promote the apoptosis of colorectal cancer cells [ 25 ]. To our best knowledge, studies investigating the correlation between BIRC5 and DR5 remain scarce, therefore it would be plausible to suggest that BIRC5/DR5 may be a novel strategy involved in lung adenocarcinoma therapy. Furthermore, we also uncovered that co-treatment of NPs and radiotherapy brought about marked elevation in cell apoptosis of lung adenocarcinoma, as evidenced by up-regulated Caspase-3 expressions. Consistently, a prior study illustrated that RBCm-OM/PLGA nanoparticles promoted the apoptosis of non-small-cell lung adenocarcinoma cells by reducing the Bcl-2 expression and elevating Caspase-3 levels [ 26 ].   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    CC prev_next  \\\n",
       "0   Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "1   Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "2   Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "3   Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "4   Data on microRNAs, the sample source, the regulatory mode of microRNAs, the target genes/proteins of microRNAs, and their effect on PTC cells from the 137 studies were selected and presented in  Table 1  [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 ].   \n",
       "..                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ...   \n",
       "68                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     To determine the correlation of dysregulated miRNAs with DDP resistance, frequently reported miRNAs related to GC were chosen to distinguish the difference between resistance and sensitivity of GC cells [ 13 - 22 ]. We detected the IC 50  of sensitive and resistance cells first and found that the IC 50  of 7901/DDP (Figure  1 A) or BGC-823/DDP (Figure  1 B) was significantly higher than that in respective sensitive cells.   \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Some circRNAs have complicated roles depending on types of cancers [ 17 ]. In thyroid cancers, aberrant expressions of circRNAs have been reported as well [ 27 ]. For example, circBACH2 contributes to papillary thyroid carcinoma [ 28 ].   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      ROCK1 functions as an oncogene in many cancer types, such as non-small lung cancer, breast cancer, ovarian cancer and prostate cancer [ 31 ,  32 ]. ROCK1 is overexpressed in PTC tissues and promotes PTC cell proliferation and invasion [ 33 ,  34 ]. Previous reports also show that miR-26a [ 35 ], miR-584 [ 36 ] and miR-150 [ 37 ] directly target ROCK1 in PTC.   \n",
       "71                                                                                                                                                                                                                                                                                                                                                                                                               Meanwhile, MNPs further serve as contributors to nanotriggers, which possess the ability to control cell function [ 10 ]. On the other hand, Baculoviral IAP repeat containing 5 (BIRC5) is up-regulated in lung adenocarcinoma cells and tissues, wherein radiosensitivity was found to influence the dependance on BIRC5 expression [ 11 ]. Moreover, genes can be inhibited by antisense oligodeoxynucleotide (AS-ODN) or by small interference RNA (siRNA), and previously been highlighted as a promising treatment avenue for lung adenocarcinoma [ 12 ].   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              BIRC5 is also reported to be one of the prognostic markers for lung adenocarcinoma [ 21 ]. Moreover, BIRC5 up-regulation was previously documented in lung adenocarcinoma cells and tissues, wherein = radiosensitivity could affect the dependence on BIRC5 expression [ 11 ]. Consistently, RT-qPCR and Western blotting results in our study revealed that BIRC5 was highly-expressed in lung adenocarcinoma.   \n",
       "\n",
       "                   Retracted DOI  \\\n",
       "0   10.1016/j.biopha.2018.03.122   \n",
       "1      10.1016/j.lfs.2020.117519   \n",
       "2     10.1016/j.omtn.2019.12.014   \n",
       "3     10.1016/j.omtn.2019.12.025   \n",
       "4   10.1016/j.biopha.2018.05.078   \n",
       "..                           ...   \n",
       "68      10.1186/1471-2407-14-218   \n",
       "69    10.1016/j.omtn.2019.12.014   \n",
       "70  10.1016/j.biopha.2018.03.122   \n",
       "71    10.1016/j.omtn.2020.09.020   \n",
       "72    10.1016/j.omtn.2020.09.020   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                           Reasons  \n",
       "0                                                                                                                                                                                                                                                                                                                                                    +Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;  \n",
       "1                                                                                                                                                                                                                                                                                   +Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;  \n",
       "2                                                                                                                                                                                                                                                                                                  +Concerns/Issues About Image;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Image;  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   +Concerns/Issues About Data;+Concerns/Issues about Results and/or Conclusions;  \n",
       "4   +Author Unresponsive;+Concerns/Issues About Data;+Duplication of/in Image;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Upgrade/Update of Prior Notice(s);\\n                                                                                                  +Concerns/Issues About Data;+Concerns/Issues About Image;+Investigation by Journal/Publisher;+Updated to Retraction;  \n",
       "..                                                                                                                                                                                                                                                                                                                                                                                                                                             ...  \n",
       "68                                                                                                                                                                                                                                                                                                                                                                      +Concerns/Issues About Data;+Concerns/Issues About Image;+Unreliable Data;  \n",
       "69                                                                                                                                                                                                                                                                                                 +Concerns/Issues About Image;+Euphemisms for Plagiarism;+Investigation by Journal/Publisher;+Investigation by Third Party;+Plagiarism of Image;  \n",
       "70                                                                                                                                                                                                                                                                                                                                                   +Duplication of/in Image;+Investigation by Third Party;+Paper Mill;+Results Not Reproducible;  \n",
       "71                                                                                                                                                                                                                         +Falsification/Fabrication of Data;+Investigation by Journal/Publisher;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Unreliable Results and/or Conclusions;  \n",
       "72                                                                                                                                                                                                                         +Falsification/Fabrication of Data;+Investigation by Journal/Publisher;+Investigation by Third Party;+Original Data and/or Images not Provided and/or not Available;+Paper Mill;+Unreliable Results and/or Conclusions;  \n",
       "\n",
       "[73 rows x 6 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pd.set_option('display.max_colwidth', None)\n",
    "dico_df = pd.DataFrame(retracted.items(), columns=['DOI','Reasons'])\n",
    "print(len(dico_df))\n",
    "display(dico_df.head(2))\n",
    "merged_df = my_df.merge(dico_df, on=\"DOI\")\n",
    "merged_df = merged_df.drop(['Section title','IMRD','Cited title'],axis = 1)\n",
    "merged_df.rename(columns={'DOI': 'Retracted DOI'}, inplace=True)\n",
    "display(merged_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "a5b25b11",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_df.to_csv('Retracted_sample', sep='\\t', index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "hey",
   "language": "python",
   "name": "hey"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
